UAB researchers discover that the immune system consistently targets the same region of mismatched HLA proteins after organ ...
Royalty Pharma has made another play in the autoimmune space, this time crowning Johnson & Johnson as the beneficiary. Royalty and J&J have agreed to co-fund the development of a chronic autoimmune ...
Six poster presentations showcase Zymeworks’ next-generation ADC programs, including multiple first-in-class pan-RAS ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
3don MSN
Immune system uses a conveyor belt-like process to edit defective antibodies, new research finds
The immune system's B cells create antibodies that can mount a response against just about anything—either destroying a ...
NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) for ...
Dr. Nooka provides comprehensive guidance on bispecific antibody safety management, emphasizing the predictable chronology of ...
Patients with elevated anti-HLA antibodies experienced significantly prolonged time to transplant — a median of 120 days ...
By Kunal Das March 31 (Reuters) - Biotech firm Infinimmune said on Tuesday it has entered into a deal with drugmaker Merck ...
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results